| | Start date | Site | Title | Topic |
|---|
| ML25052A187 | 2 April 2025 | | Memo Thorium Generators 21 Feb 25 | |
| ENS 57571 | 25 February 2025 08:00:00 | Hoag Hospital Irvine | Medical Event | |
| ML24299A002 | 25 October 2024 | | ACMUI November 4 - 5 2024 Meeting Handout | Enforcement Discretion Brachytherapy TheraSphere |
| ML24135A321 | 14 May 2024 | Pilgrim Holtec | Annual Radioactive Effluent Release Report, January 1 Through December 31, 2023 | Grab sample Offsite Dose Calculation Manual Met Tower Annual Radioactive Effluent Release Report Annual Radiological Environmental Operating Report Process Control Program Annual Radiological Effluent Release Report Grace period |
| ML24012A155 | 12 January 2024 | | M240118: Slides - J. Lubinski - Strategic Programmatic Overview of the Decommissioning and Low-Level Waste and Nuclear Materials Users Business Lines | Machine learning |
| ML24004A125 | 12 January 2024 | 07109338 | Certificate of Compliance No. 9338, Revision No. 5 | |
| ML23320A242 | 16 November 2023 | | Ots Chapter 246-231 Wac Package Transportation (002) | Condition Adverse to Quality Exclusive Use Depleted uranium |
| ML23241A914 | 23 August 2023 | | T180-13 Effective 2021-04-05 Highlighted | Incorporated by reference Condition Adverse to Quality Exclusive Use Depleted uranium |
| ML23241A917 | 23 August 2023 | | T180-13 Effective 2022-11-02 Highlighted | Incorporated by reference Condition Adverse to Quality Exclusive Use Depleted uranium |
| ML23234A303 | 22 August 2023 | University of California - Irvine | University of California – Irvine, Annual Operating Report of 2022-2023 in Accordance with Technical Specification 6.7.1 | |
| ML23178A090 | 10 July 2023 | | Responses to the Advisory Committee on the Medical Uses of Isotope’S Recommendations on Draft Proposed Revision 2 to Regulatory Guide 8.39,Release of Patients Administered Radioactive Materials | |
| ML23167A360 | 14 June 2023 | | Wac Chapter 246-231 Packaging and Transportation of Radioactive Material | Condition Adverse to Quality Exclusive Use Depleted uranium |
| ML23125A316 | 15 May 2023 | | Advisory Committee on the Medical Uses of Isotopes (ACMUI) Spring 2023 Meeting Handout, May 15, 2023 | Decommissioning Funding Plan Accidental discharge Brachytherapy Stolen Eye plaque TheraSphere Overdose Underdose |
| ML23135A215 | 15 May 2023 | Pilgrim | Annual Radioactive Effluent Release Report, January 1 Through December 31, 2022 | Grab sample Offsite Dose Calculation Manual Met Tower Annual Radioactive Effluent Release Report Annual Radiological Environmental Operating Report Process Control Program Annual Radiological Effluent Release Report |
| ML23125A317 | 5 May 2023 | | NRC Staff Medical Event Slides, May 15, 2023, FY22 Events | Accidental discharge Brachytherapy Eye plaque TheraSphere Overdose Underdose |
| ML21230A318 | 30 April 2023 | | DG 8061 (RG 8.39 Rev 2) Release of Patients Administered Radioactive Material | Brachytherapy Eye plaque |
| ML23017A113 | 18 April 2023 | PROJ0734 | Technical Review: Dose and Exposure Pathways Model for the 2020 Saltstone Disposal Facility Performance Assessment - CR | Potassium iodide |
| A25396, Msre Tru Waste Determination LA-UR-10-07278 | 14 April 2023 | Abilene Christian University | Msre Tru Waste Determination LA-UR-10-07278 | |
| SECY-23-0030, Weekly Information Report Week Ending March 24, 2023 | 31 March 2023 | | SECY-23-0030: Weekly Information Report Week Ending March 24, 2023 | Aging Management Open House License Renewal Subsequent License Renewal Application |
| STC-23-016, Notification of Upcoming DOE Isotope Program Virtual Roundtable on Accelerator-Produced Actinium-225 with the NRC | 17 March 2023 | | STC-23-016 - Notification of Upcoming DOE Isotope Program Virtual Roundtable on Accelerator-Produced Actinium-225 with the NRC | |
| ML22335A591 | 2 November 2022 | 07007036 | Enclosure 2 Summary Open Session | Pre-application |
| STC-22-057, Proposed Rule: Harmonization of Transportation Safety Requirements with International Atomic Energy Agency Standards (Rin 3150-AJ85; NRC-2016-0179) (STC-22-057) | 12 September 2022 | | Proposed Rule: Harmonization of Transportation Safety Requirements with International Atomic Energy Agency Standards (Rin 3150-AJ85; NRC-2016-0179) (STC-22-057) | Aging Management Exemption Request Backfit Uranium Hexafluoride Exclusive Use |
| ML22223A178 | 11 August 2022 | | VA Amended Regulations 12VAC5-481 | Cyber Security Brachytherapy |
| ML22136A258 | 16 May 2022 | Pilgrim | Annual Radioactive Effluent Release Report for January 1 Through December 31, 2021 | Grab sample Offsite Dose Calculation Manual Met Tower Annual Radioactive Effluent Release Report Annual Radiological Environmental Operating Report Process Control Program Annual Radiological Effluent Release Report |
| ML22131A271 | 9 May 2022 | | Georgia Regulations Markup 2021 | High Radiation Area Incorporated by reference License Renewal Earthquake Brachytherapy Exclusive Use Overexposure Depleted uranium |
| ML22089A189 | 5 April 2022 | | Advisory Committee on the Medical Uses of Isotopes (ACMUI) Spring Meeting 2022 Handout | Brachytherapy Stolen TheraSphere Overexposure Overdose Underdose |
| ML22101A079 | 23 March 2022 | Crane | TMI2-EN-RPT-0001, Revision 1, Determination of the Safe Fuel Mass Limit for Decommissioning | Grab sample |
| ML22066A310 | 4 March 2022 | | CRCPD Part T | Exclusive Use Depleted uranium |
| ML22026A365 | 26 January 2022 | | CRCPD Part D Draft | High Radiation Area Deep Dose Equivalent Brachytherapy Stolen |
| ML22021B300 | 21 January 2022 | | Advisory Committee on the Medical Uses of Isotopes (Acmui), Subcommittee on RG 8.39, Release of Patients Administered Radioactive Material, Review and Comment on Draft Proposed Revision 2 to Regulatory Guide 8.39, Final Report, January 21, | |
| ML22010A067 | 5 January 2022 | Crane | Supplemental Information to License Amendment Request, Revision to TMl2-EN-RPT-0001 Determination of the Safe Fuel Mass Limit for Decommissioning TMl-2 | Grab sample |
| ML21351A309 | 21 December 2021 | 07109337 | CoC 9337 Revision 5 | |
| ML21341B436 | 15 December 2021 | | Advisory Committee on the Medical Uses of Isotopes (ACMUI) December 15, 2021 Teleconference Meeting Handout | Brachytherapy Stolen Eye plaque |
| ML21341A564 | 1 December 2021 | | Advisory Committee on the Medical Uses of Isotopes (Acmui), Subcommittee on RG 8.39 Release of Patients Administered Radioactive Materials, Review and Comment on Draft Proposed Revision 2 to Regulatory Guide 8.39, Draft Report, December 15, | |
| ENS 55603 | 20 November 2021 03:45:00 | City Of Hope | Underdose of Patient | Accidental discharge Underdose |
| ML21301A025 | 25 October 2021 | | Tennessee Regulations 0400-20-05 | High Radiation Area Deep Dose Equivalent Chernobyl Brachytherapy Stolen Exclusive Use |
| ML21272A165 | 4 October 2021 | | Advisory Committee on the Medical Uses of Isotopes (ACMUI) October 4, 2021 Fall Meeting Handout | Coronavirus COVID-19 COVID19 Brachytherapy Eye plaque TheraSphere |
| ML21193A320 | 7 July 2021 | | Nd Chapter 33.1-10-13.1 | Incorporated by reference Condition Adverse to Quality Uranium Hexafluoride Exclusive Use Depleted uranium |
| ML21279A213 | 30 June 2021 | 07103099 | Canadian Certificate of Approval No. CDN/2101/B(U), Docket No. 71-3099 | Depleted uranium |
| ML21049A060 | 23 February 2021 | 07109337 | Renewed Certificate of Compliance 9337 | |
| ML20303A306 | 27 October 2020 | | Ks Cross Reference 2015-3, Revisions to Transportation Safety Requirements and Harmonization with International Atomic Energy Agency Transportation Requirements; Including Corrections | Incorporated by reference Depleted uranium |
| ML20261H508 | 3 September 2020 | | Nd Regulations 33.1-10-13.1 | Incorporated by reference Condition Adverse to Quality Uranium Hexafluoride Exclusive Use Depleted uranium |
| ML20120A220 | 29 April 2020 | 07000925 | Environmental Properties Management, LLC - EPA Calculation of Maximum Contaminant Level for Technitium-99 | |
| ML20083H608 | 14 April 2020 | 07109338 | Certificate of Compliance No. 9338, Revision No. 4, for the Model No. 3977A Package | |
| ML20083J962 | 14 April 2020 | 07109338 | Certificate of Compliance No. 9338, Revision No. 4, for the Model No. 3977A Package Safety Evaluation Report | Exclusive Use Depleted uranium |
| ML20085H267 | 25 March 2020 | | Advisory Committee on the Medical Uses of Isotopes (ACMUI) Subcommittee on Regulatory Guide 8.39, Release of Patients Administered Radioactive Material, Draft Final, Revision 1 (Phase 1), Final Report, March 25, 2020 | |
| ML20056E123 | 11 March 2020 | | Advisory Committee on the Medical Uses of Isotopes (ACMUI) March 11, 2020 Meeting Ebinder | Brachytherapy |
| ML20056D823 | 24 February 2020 | | Advisory Committee on Medical Uses of Isotopes (ACMUI) Subcommittee on the Regulatory Guide 8.39, Release of Patients Administered Radioactive Materials, Draft Final Revision 1 (Phase 1), Draft Report, February 24, 2020 | |
| ML19343A006 | 3 December 2019 | 07109338 | Ctr 2018/01, Issue D, SAFKEG-HS 3977A, Sarp Update Matrix for Thorium Target | Exclusive Use |
| ML19343A008 | 3 December 2019 | 07109338 | Ctr 2008/11, Rev 17, SAFKEG-HS 3977A, Chapter 1, General Information | Non-Destructive Examination Exclusive Use Depleted uranium |